https://scholars.lib.ntu.edu.tw/handle/123456789/473325
Title: | Targeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines | Authors: | Wu H.-H. Hwang-Verslues W.W. Lee W.-H. Huang C.-K. Wei P.-C. Chen C.-L. Shew J.-Y. Lee E.-Y.-H.P. YUNG-MING JENG YU-WEN TIEN Ma C. Lee W.-H. |
Issue Date: | 2015 | Publisher: | Rockefeller University Press | Journal Volume: | 212 | Journal Issue: | 3 | Start page/Pages: | 333-349 | Source: | Journal of Experimental Medicine | Abstract: | Pancreatic cancer has an extremely high mortality rate due to its aggressive metastatic nature. Resolving the underlying mechanisms will be crucial for treatment. Here, we found that overexpression of IL-17B receptor (IL-17RB) strongly correlated with postoperative metastasis and inversely correlated with progression-free survival in pancreatic cancer patients. Consistently, results from ex vivo experiments further validated that IL-17RB and its ligand, IL-17B, plays an essential role in pancreatic cancer metastasis and malignancy. Signals from IL-17B-IL-17RB activated CCL20/CXCL1/IL-8/TFF1 chemokine expressions via the ERK1/2 pathway to promote cancer cell invasion, macrophage and endothelial cell recruitment at primary sites, and cancer cell survival at distant organs. Treatment with a newly derived monoclonal antibody against IL-17RB blocked tumor metastasis and promoted survival in a mouse xenograft model. These findings not only illustrate a key mechanism underlying the highly aggressive characteristics of pancreatic cancer but also provide a practical approach to tackle this disease. ? 2015 Wu et al. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84924700441&doi=10.1084%2fjem.20141702&partnerID=40&md5=c90590c01fea3919635dfd976461dacb https://scholars.lib.ntu.edu.tw/handle/123456789/473325 |
ISSN: | 0022-1007 | DOI: | 10.1084/jem.20141702 | SDG/Keyword: | antineoplastic agent; CXCL1 chemokine; cytokine; interleukin 17B; interleukin 17B receptor; interleukin 17B receptor antibody; interleukin 8; macrophage inflammatory protein 3alpha; mitogen activated protein kinase; monoclonal antibody; unclassified drug; chemokine; interleukin 17; interleukin 17 receptor; monoclonal antibody; adult; animal experiment; animal model; antineoplastic activity; Article; cancer cell; cancer growth; cancer inhibition; cancer localization; cancer survival; cell invasion; drug targeting; endothelium cell; female; gene overexpression; human; macrophage; male; metastasis; mouse; nonhuman; pancreas cancer; priority journal; progression free survival; signal transduction; animal; disease free survival; drug screening; gene expression regulation; genetics; immunology; metabolism; middle aged; mortality; Pancreatic Neoplasms; pathology; SCID mouse; Animals; Antibodies, Monoclonal; Chemokines; Disease-Free Survival; Female; Gene Expression Regulation, Neoplastic; Humans; Interleukin-17; Male; Mice, SCID; Middle Aged; Pancreatic Neoplasms; Receptors, Interleukin-17; Signal Transduction; Xenograft Model Antitumor Assays |
Appears in Collections: | 病理學科所 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.